Geoffrey Duyk

Dr. Duyk is a partner of Circularis Partners, an investment firm focused on supporting technology-enabled companies that advance the circular economy, promote sustainability and enhance resource efficiency. Previously, he was managing director and partner of TPG Alternative & Renewable Technologies (ART)/TPG Biotechnology. Among Dr. Duyk’s prior work affiliations are Harvard Medical School assistant professor, and Howard Hughes Medical Institute assistant investigator. Dr. Duyk serves on the Board of Directors of Amyris (Nasdaq: AMRS), Concentric and Regen. He is a trustee of Case Western Reserve University and a member of the Institute Board of Directors for the Moffitt Cancer Center. Dr. Duyk holds a Ph.D. and M.D. from Case Western Reserve University. He completed his medical and fellowship training at the University of California, San Francisco (UCSF) and is a Fellow of the American Association for the Advancement of Science.